| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1033310641 |
| P356 | DOI | 10.1023/A:1015500531113 |
| P698 | PubMed publication ID | 12083418 |
| P2093 | author name string | Mostafa Badr | |
| Bradley K Taylor | |||
| Sendhil Krishnan | |||
| Carolyn B Yang | |||
| Niren Dadia | |||
| P2860 | cites work | PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL | Q24311741 |
| The PPARs: from orphan receptors to drug discovery | Q28371618 | ||
| Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells | Q28373520 | ||
| trans-Activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals | Q28377239 | ||
| Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2 | Q28619368 | ||
| PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines | Q29620217 | ||
| The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation | Q29620219 | ||
| A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia | Q29620385 | ||
| An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer | Q33690773 | ||
| Biology of senescent liver peroxisomes: role in hepatocellular aging and disease | Q33742431 | ||
| The peroxisome proliferator-activated receptor(PPARgamma) as a regulator of monocyte/macrophage function. | Q33782023 | ||
| Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia. | Q33876924 | ||
| Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation | Q34088380 | ||
| Peroxisome proliferator-activated receptors in inflammation control | Q34262753 | ||
| Hepatic peroxisome proliferation in rodents and its significance for humans | Q40789308 | ||
| Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo | Q40908023 | ||
| N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents | Q40991138 | ||
| Extraperoxisomal targets of peroxisome proliferators: mitochondrial, microsomal, and cytosolic effects. Implications for health and disease | Q41717055 | ||
| PPARgamma in monocytes: less pain, any gain? | Q41755827 | ||
| The PPARalpha-leukotriene B4 pathway to inflammation control. | Q42552721 | ||
| PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation | Q42832963 | ||
| Metabolism of diethylhexyl phthalate by rats. Isolation and characterization of the urinary metabolites | Q69486135 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 121-127 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Inflammation | Q2560341 |
| P1476 | title | Peroxisome proliferator-activated receptor agonists inhibit inflammatory edema and hyperalgesia | |
| P478 | volume | 26 |
| Q26995053 | A lipid gate for the peripheral control of pain |
| Q33618276 | Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema. |
| Q51358469 | Alteration of neuropathic and visceral pain in female C57BL/6J mice lacking the PPAR-α gene. |
| Q45891909 | Attenuation of pain-related behaviour evoked by carrageenan injection through blockade of neuropeptide Y Y1 and Y2 receptors. |
| Q49221673 | Biotransformation of polyunsaturated fatty acids to bioactive hepoxilins and trioxilins by microbial enzymes |
| Q44249631 | Effects of perfluorooctane sulfonate (PFOS) exposure on markers of inflammation in female B6C3F1 mice |
| Q37959888 | Immunotoxicity of perfluorinated compounds: recent developments. |
| Q23914416 | Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha |
| Q28218456 | Inhibition of Carrageenan-Induced Cutaneous Inflammation by PPAR Agonists Is Dependent on Hepatocyte-Specific Retinoid X ReceptorAlpha |
| Q41832173 | Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors |
| Q41876697 | Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats |
| Q39750509 | Involvement of the Retinoid X Receptor Ligand in the Anti-Inflammatory Effect Induced by Peroxisome Proliferator-Activated Receptor γ Agonist In Vivo |
| Q34333206 | Levels of neuropeptide Y in synovial fluid relate to pain in patients with knee osteoarthritis |
| Q42657017 | N-acylethanolamine acid amidase (NAAA), a new path to unleash PPAR-mediated analgesia |
| Q37122891 | Nuclear receptors and inflammatory diseases |
| Q47114262 | PPAR-α acutely inhibits functional activity of ASICs in rat dorsal root ganglion neurons |
| Q60680364 | PPARs and pain |
| Q34630884 | Perfluoroalkyl acids: a review of monitoring and toxicological findings |
| Q33608432 | Peripheral gating of pain signals by endogenous lipid mediators |
| Q89896232 | Pharmacological Blockade of PPAR Isoforms Increases Conditioned Fear Responding in the Presence of Nociceptive Tone |
| Q37024759 | RAR/RXR and PPAR/RXR Signaling in Spinal Cord Injury |
| Q36964412 | Rapid pain modulation with nuclear receptor ligands |
| Q36591722 | Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases? |
| Q24796541 | Role of Peroxisome Proliferator-Activated Receptors in Inflammation Control |
| Q36540016 | Significance of anti-inflammatory effects of PPARgamma agonists? |
| Q48323975 | Structural improvement of new thiazolidinones compounds with antinociceptive activity in experimental chemotherapy-induced painful neuropathy |
Search more.